Covid Inquiry: Former chief medical officer close to tears over pandemic deaths
Dame Sally Davies apologises to bereaved families and says the UK was poorly prepared for the pandemic.
Similar Posts
WHO warns pandemic treaty deadline may be missed
Join Fox News for access to this content Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the…
Get measles vaccine to avoid rapid spread, says UK health boss
People have forgotten how miserable it is to have measles, a top health official warns.
States have been eliminating taxes on period products for years.
Packages of Tampax brand tampons on a drugstore shelf in New York on Wednesday, February 10, 2016. Richard Levine | Corbis News | Getty Images Over a lifetime, period products in the U.S. cost a total of around $6,000 per person, according to research published in 2021 — and that’s before tax. In 21 states, a sales tax…
Ear infections in kids could lead to delayed speech, study shows
Chronic ear infections could delay a child’s language development, new research suggests. University of Florida researchers launched a study about how the common childhood infection could impact speech. Early ear infections (otitis media) have the potential to impair hearing due to fluid buildup behind the eardrum, according to the study, which was published in the…
Health officials warn of possible measles exposure at Dulles, Ronald Reagan airports
Health officials in the nation’s capital are warning of a possible measles exposure Tuesday after a person with a “confirmed case” traveled through two of the busiest airports in the region while returning home from an international trip. DC Health says the potential exposure occurred in the international arrivals area of the main terminal at…
Zepbound is off to a strong start, but here’s what Eli Lilly investors are watching
Hopes are sky-high for Eli Lilly’s recently launched weight loss drug Zepbound. Investors will be tuning into the company’s fourth quarter earnings call on Feb. 6, eager to hear more about how that rollout is going. One key statistic will be the number of commercial health insurers providing coverage of the drug, which was approved…